Psychedelics Today

In this episode, recorded on the eve of MAPS’ Psychedelic Science 2023, Kyle interviews MAPS’ Founder and President, Rick Doblin, Ph.D. He begins with an overview of the fast-approaching (and largest ever) psychedelics conference, emphasizing its significant growth, many features, and bipartisan opening ceremony, then discusses MAPS’ soon-to-be-released confirmatory Phase III data on MDMA-assisted therapy for PTSD, which should set the stage for legal MDMA and the increasing need for trained psychedelic therapists.  As the FDA is requiring studies on adolescents, he discusses this sensitive issue and questions why it’s so controversial, since teenage years are often closer to both trauma and a more malleable brain, Indigenous traditions certainly didn’t have age limits, and honest drug education – something that is absolutely necessary to fight the backlash against this quickly growing field – teaches us that it’s not the substance; it’s our relationship to it. Could not having these rites of passage be hurti

In this episode, Joe interviews Sarko Gergerian, MS, MHC, CARC: a police peer support, community outreach, and health-fitness officer; founding member of the Community and Law Enforcement Assisted Recovery Program (C.L.E.A.R.); and psychotherapist trained in ketamine- and MDMA-assisted psychotherapy. Any regular listener of the show should be familiar with how passionately Joe is against the drug war and the resulting policing of what many of us feel should be legal, so this in-person conversation with a police officer who seems to mostly be on our side is pretty refreshing to hear.  Gergerian discusses his entry into the force in his 30s, and what it was like to bring in a healthy “why is this illegal?” viewpoint on drug use and personal agency vs. the slow moving attitudes he saw in much of law enforcement. He talks about how working nightclub security taught him about safe spaces; the problems with officers not proactively moving on actionable information and building relationships with communities; and th

In this episode, Joe interviews one of the world’s leading experts on human performance: New York Times bestselling author and Executive Director of the Flow Research Collective, Steven Kotler. Kotler's work explores the neurobiology of peak human performance, flow states, and aging, and the concept of getting our biology to work for us rather than against us in our later years, by using the parts of our brains that expand in our 50s, combined with neuroplasticity, learning by play, and the biggest factor: working toward a very difficult - but not impossible - task. His 30-year exploration of the neurobiology behind people accomplishing 'impossible' feats led him to test his theories by teaching himself to park ski at 53 with resounding success, then using his protocol with people up to 70 years old the next season. The story is told in his newest book about challenging tired concepts of aging, "Gnar Country."  He discusses the power of flow states and how much flow actually amplifies productivity, motivation

In this episode, David interviews Dr. Gabrielle Lehigh: Co-Founder and Managing Director of Psychedelic Grad, a web-based community serving as an educational and career hub for up-and-coming psychedelic professionals; and the host of the related podcast, “Curious to Serious,” where she speaks with students and professionals about the path they took to land in the psychedelic field.  Lehigh recently earned her Ph.D. with research on something not many are looking at: the stories behind powerful and transformative psychedelic experiences specifically at music events, based on 38 interviews and over 500 surveys mostly collected at day-long festivals in the southern United States. While the goal was largely data collection in support of the clear potential for therapeutic benefit in using psychedelics in recreational settings (as many of us who have experienced this can attest), she was surprised to learn how many people still blindly trust dealers; how much festival security can affect safety; how the community

In this episode, Kyle interviews the Reverend Dr. Brian Rajcok, Lead Pastor at St. Matthew Lutheran Church in Avon, Connecticut, who recently completed his Ph.D. in pastoral counseling. Rajcok dives into the intersection of spirituality, religion, mysticism, and how psychedelics bring these topics together, discussing a transformative peyote ceremony and the awe-inspiring moments of surrender, connection, and divine presence that left a lasting impact on him and deepened his connection to God. And he talks about his recently completed dissertation that was inspired by it all: "The Lived Experience of Professional Mental Health Clinicians With Spiritually Significant Psychedelic Experiences," which he created to gauge the relationship between religious spiritual commitment, tolerance, and multicultural counselor competency. He shares stories from the study and reflections on how these experiences have changed the way involved clinicians work.  And he discusses much more in the realm of psychedelics and religio

In this episode, David interviews Dr. Rosalind Watts: famed clinical psychologist, former clinical lead on Imperial College London’s first Psilocybin for Depression trial, and Founder of ACER Integration.  She discusses the awakening she had after having a child; her work at Imperial College and realizing the importance of staying in touch with patients; the challenges of balancing her work with being a mother; her ACER integration model and the interconnectedness of trees in a forest; how the Watts Connectedness Scale works (and David fills it out); and how much the outside-the-hype surrounding pieces matter – the therapy, the therapeutic relationship, the lessons learned, and the work done to integrate it all.  And she talks about another moment of awakening, at last year's Psych Summit conference, where capitalism's obsession with profit-over-care frameworks and "magic bullet" and "brain reset" narratives was on full display, which fully enforced what she hopes for in the future: a world where we embrace n

In this episode, Joe interviews Oliver Carlin, Founder of Curative Mushrooms, a grow kit solution company designed to produce mushrooms of one’s choosing within 30 days with little effort and no growing experience.  Carlin tells his personal story of 20 years in the Navy to a 7g psilocybin journey and the work of perfecting these grow bags; how a grow bag works; how easy it can be to grow your own mushrooms; the advantages of growing your own mushrooms vs. buying them; the legalities of grow kits and how he has been able to do this; steps growers can take to reduce their legal risks; the variety of people benefitting from mushrooms (especially in the veteran community); and how growing your own mushrooms seems to make the experience more curated and special. Curative Mushrooms recently hired someone to create new strains for them every month, they do bimonthly live Q&As for people interested in growing, and they ship a bonus mycology book with each kit that shows how to study spores. They offer growing ki

In this episode, David interviews Dr. Roberta Murphy: member of the Imperial Centre for Psychedelic Research and training medical psychotherapist. This is a rare impromptu podcast, recorded about a half hour after David heard Murphy speaking on a panel at UK’s Breaking Convention conference. He asked her if she wanted to be on the podcast sometime, and before they knew it, they were recording. Fastest turnaround ever? She discusses her past research and what she's doing at Imperial College; her work on a psilocybin for depression trial; a psilocybin versus Escitalopram trial; her hopes for psychedelics treating people with Parkinson's; and her recent co-written paper on the ARC Framework (Access, Reciprocity and Conduct), where she will be focusing strongly on the Conduct aspect through her work at Imperial.  She mostly talks about her other recent paper exploring the impact of one of the more important aspects of therapy: the therapeutic alliance on the psychedelic experience. How does the treatment dynamic

In this episode, Alexa interviews Rachel Clark: Education Manager for DanceSafe, a public health nonprofit specializing in serving people who use drugs and their communities. As we move into the prime festival season, more people are going to be doing drugs, and the importance of harm reduction and drug testing becomes even more central to the experience. She discusses the complications of drug testing and how it’s more of an act of ruling substances out rather than determining purity; the fentanyl problem and its surrounding myths; how to identify and treat an overdose (and what not to do); Philadelphia’s struggles with Xylazine highlighting the problem with regional cross contamination; and DanceSafe’s “We Love Consent” and “Healing is Power” campaigns, which aim to open up the dialogue of true harm reduction and safe spaces outside of the substance alone. Check out DanceSafe.org for more info, and use this link when you’re ready to make a purchase! psychedelicstoday.com

In this episode of Psychedelics Weekly, Joe and Alexa reminisce about last week's Psychedelic Science 2023, dubbed as the largest psychedelic conference in history.  They discuss Joe's two Psychedelic Morning Shows with Anne Philippi; Court Wing, Bob Wold, and the work of Clusterbusters and the new Psychedelics and Pain Association; Aaron Rogers and athletes' growing interest in psychedelics; the legality of mushroom growing kits; and the overall fun and overwhelming atmosphere of such a massive event. And as Alexa had her first breathwork session with the East Institute, they dig more into breathwork, which serves as somewhat of a follow-up to our breathwork episode a few weeks ago.   They also talk about a short film they came across called "Open Up," which looks at the party lifestyle of always seeking a new high, the potential of ketamine abuse, and what can happen when people don't talk about their problems. https://psychedelicstoday.com/2023/06/30/psychedelics-weekly-a-recap-of-psychedelic-science-2023

In this episode, David interviews Professor Celia Morgan, Ph.D., who holds the Chair of Psychopharmacology and co-leads the Transdisciplinary Psychedelics Group at The University of Exeter. This was recorded on the dawn of UK's Breaking Convention conference, where Morgan was speaking about the therapeutic potential of ketamine as well as the danger of people developing a dependence on it. She touches on that topic, but largely discusses her current Phase III Trial for ketamine-assisted therapy for the treatment of severe alcohol use disorder (also called the KARE model (Ketamine for reduction of Alcohol Relapse)), a collaboration with Awakn Life Sciences. She discusses her other research: studies on mindfulness intervention before and after ketamine, epigenetic changes after ayahuasca use, the antidepressant qualities of ayahuasca, and CBD for cannabis dependence. And she talks about the necessary balance for making treatments amazing but affordable; how connecting with nature during integration is key; how

In the second episode of our special, two-part series, the Psychedelic Morning Show, Joe Moore and Anne Philippi are live once again bright and early from Psychedelic Science 2023 in Denver. Listen to this podcast as they interview four guests working on the front lines of psychedelic research, law, and the treatment of chronic pain.  Guests for this episode include:  Tommaso Barba – PhD candidate at Centre for Psychedelic Research, Imperial College London Allison Hoots – Attorney at Hoots Law Practice and advocate; President of Sacred Plant Alliance Bob Wold - Founder & President, Clusterbusters Court Wing – Founder, REMAP Therapeutics  psychedelicstoday.com

Psychedelics Today is reporting live this week from the industry event of the year, Psychedelic Science 2023 in Denver. Listen in to this podcast as our co-founder, Joe Moore, and New Health Club founder Anne Philippi hit the conference floor bright and early in the first episode of a special two-part series, the Psychedelic Morning Show. In this limited series, Joe and Anne chat in real-time with guests working in all corners of the psychedelic ecosystem, from advocacy, law and finance, to research and therapy.  Guests for this episode include:  Dr. Julie Holland – Psychiatrist, psychedelic researcher, author and medical advisor for MAPS Daniel Goldberg – Co-Founder and Principal at Bridge Investments & Palo Santo Hadas Alterman – Director of Government Affairs | American Psychedelic Practitioners Association Melissa Lavasani – Founder and Chief Executive Officer at Psychedelic Medicine Coalition, Founder and President of Psychedelic Medicine PAC Tracey Tee – Founder of Moms on Mushrooms psychedelicsto

In this episode, David interviews Frederick Barrett, Ph.D.: cognitive neuroscientist, Associate Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine, and now, Director of the Johns Hopkins Center for Psychedelic & Consciousness Research. With today’s news, Barrett officially takes over for the legendary Roland Griffiths, who has been in the role since the Center’s launch in 2019, and who will continue on as a member of the leadership team while dealing with the Stage 4 cancer diagnosis he has been remarkably candid about in recent interviews.  Dr. Barrett has been conducting research at Johns Hopkins for a decade, authoring or co-authoring some of the first studies on psilocybin’s enduring effects, and receiving the first federally funded human psychedelic research grant from the NIH since the 70s. He discusses the work and importance of Roland Griffiths; the history of the Center and current research he’s most excited about; the mystery of consciousness; and the

In this edition of Psychedelics Weekly, Joe and Kyle dedicate the entire episode to one of their biggest passions: breathwork and the power of breath in reaching non-ordinary states of consciousness. What many listeners may not know is that Psychedelics Today was created because of the lack of attention being paid to breathwork, transpersonal psychology, and the work of Stanislav Grof, so this episode serves as a deep dive into all the facets of our fascinating ability to reach psychedelic states simply by breathing in specific ways. They discuss the history of breathwork; the various methods (box breathing, alternate nostril breathing, rebirthing breathwork, the Wim Hof method, Holotropic and Transpersonal breathwork, etc.); early and most powerful experiences; why Joe recommends becoming familiar with breathwork before a first psychedelic experience; how a breathwork practice can help enhance psychedelic experiences; and one of the most amazing things about breathwork: that it can give people a sense of age

In this episode, Kyle interviews Liana Gillooly: Strategic Initiatives Officer at MAPS, Board Chair & Founder of the non-profit, North Star, and Advisor to Chacruna’s Indigenous Reciprocity Initiative. While she talks about updates in MAPS’ world and how to manage and scale a rapidly growing industry while trying to change a system from the inside, she mostly talks about what she, the rest of MAPS, and a lot of the psychedelic space in general are most excited about right now: Psychedelic Science 2023, the largest psychedelic conference in history, beginning next week in Denver.  She discusses the growth of the conference; why they chose Denver as a location; and how programming has changed over the years to embrace the multiplicity of identities inside the psychedelic space, including much more business content, a culture stage that focuses on how psychedelics interact with the mainstream, various programs put on by community partners, pre- and post- workshops covering an array of topics, and an area the

In this episode, David interviews Alex Belser, Ph.D.: clinical scientist; author; licensed psychologist; Co-Investigator for a psilocybin and OCD study at Yale University; and co-creator of the EMBARK approach, a new model of psychedelic-assisted therapy that focuses on six clinical domains that typically arise during psychedelic experiences. He is also one of the editors of "Queering Psychedelics: From Oppression to Liberation in Psychedelic Medicine," the new anthology from Chacruna featuring 38 essays from queer authors and allies looking at the heteronormative aspects of psychedelic culture and psychedelic-assisted psychotherapy, self-acceptance, psychedelics and pleasure, and ways the queer community can become allies with other groups. As they serendipitously recorded this episode on June 1, it only made sense to celebrate Pride Month by releasing it now, as well as launching a giveaway, where you can win one of five copies of "Queering Psychedelics."  Belser talks about the concurrent emergence of the

In this episode of Psychedelics Weekly, Joe and Kyle are once again able to take advantage of Kyle's temporary Colorado residency and record together in Joe's office. While last week focused on the numerous challenges facing a rapidly growing industry of psychedelic therapists, facilitators, and guides, the topic of therapy itself is put under the microscope this week, as they dissect a New York Times article titled, "Does Therapy Really Work? Let’s Unpack That." They discuss whether or not therapy is right for everyone, the efficacy of different types of therapy, the role of the therapeutic alliance in treatment outcomes, and how (if it's even possible) to measure all of these factors. They also discuss: -a study showing that ketamine was more effective than ECT (electroconvulsive therapy) for patients with treatment-resistant depression; -the potential benefits of the LSD analog, Br-LSD, in treating people with major depressive disorders, cluster headaches, and more; -Ireland's Health Service Executive laun

In this episode, Joe interviews the Co-Founders of Enosis Therapeutics: researcher and scientist, Agnieszka Sekula; and psychiatrist, clinical advisor to the Australian Psychedelic Society, and leading Australian advocate for psychedelic-assisted psychotherapy, Dr. Prash P.  Enosis Therapeutics is a medtech startup that began with the question: how can we use VR – with or without psychedelics – to improve mental health outcomes? They feel that the biggest problem with powerful psychedelic experiences is that, once you’re back in reality, it’s oddly difficult to remember the insights and new ideas that were so clear during the experience, and even harder to make connections that lead to concrete change. They believe that the immersive nature of VR and the novelty of unique VR environments creates a sense of presence that can’t be recreated otherwise – a liminal, in-between state that’s just different enough to allow the patient to feel like they’re back in that non-ordinary state, and therefore more able to an

In this episode of Psychedelics Weekly, Kyle and David meet up to talk news, but end up mostly having a discussion about the numerous challenges facing the rapidly growing industry of psychedelic therapists, guides, and facilitators. That discussion comes from the article, “Psychedelic workers of the world, unite!”, which breaks down the shortcomings and risks of an industry many are flocking to without realizing what they’ll likely have to deal with: unprecedented legal and financial risks, burnout, misalignment with management, transference and countertransference, and what happens when one finds themselves in the middle of a genuine emergency? While these issues could be found in any industry, a big reason why they seem so prevalent and dangerous in the psychedelic world is our lack of elders and passed-down experience – and the faster this all grows, the more we need that guidance.  And for news, they talk about Ohio State making history as the first U.S. University to receive a license to grow psilocybin